GIM/FP/GP:[Formula: see text] Cardiology:[Formula: see text].

Screening tools for interpersonal firearm violence (FV) are needed to facilitate prevention.

GIM/FP/GP:[Formula: see text] Cardiology:[Formula: see text].

GIM/FP/GP:[Formula: see text] Infectious Disease:[Formula: see text] Critical Care:[Formula: see text] Pulmonology:[Formula: see text].

GIM/FP/GP:[Formula: see text] Endocrinology:[Formula: see text].

Emergency Med:[Formula: see text] GIM/FP/GP:[Formula: see text] Hematology:[Formula: see text].

Emergency Med:[Formula: see text] GIM/FP/GP:[Formula: see text] Hematology:[Formula: see text].

Mental Health:[Formula: see text] GIM/FP/GP:[Formula: see text].

GIM/FP/GP:[Formula: see text] Rheumatology:[Formula: see text].

GIM/FP/GP:[Formula: see text] Neurology:[Formula: see text] Hematology:[Formula: see text].

GIM/FP/GP:[Formula: see text] Endocrinology:[Formula: see text].

The One Big Beautiful Bill Act (H.R.1) implemented Medicaid work requirements for beneficiaries in states participating in the Affordable Care Act, but congressional policymakers are considering extending work requirements nationally to all Medicaid enrollees. However, little is known about Medicaid-enrolled adults at risk of disenrollment.

Postacute sequelae of SARS-CoV-2, or long COVID, presents a major therapeutic challenge, with fatigue being a prevalent and debilitating symptom.

Recurrent kidney stones are unpleasant and may lead to kidney damage, sepsis, or invasive procedures.

Pegfilgrastim-induced bone pain (PIBP) is common and lacks effective treatment.

Firearm acquisitions in the United States surged after the onset of the pandemic. The increase, sustained through at least early 2021, resulted from a modest increase in the proportion of long-standing gun owners who purchased firearms (most were White and men) and an unprecedented increase in the proportion of adults who became new gun owners (half were women; half were Hispanic and/or people of color). Little is known about firearm acquisitions beyond 2021.

Evidence-based decision making in health often requires comparison of multiple options for a given condition. The GRADE (Grading of Recommendations Assessment, Development and Evaluation) evidence-to-decision (EtD) framework provides a structured approach for moving from evidence to decisions but was originally designed for pairwise comparisons. Hence, there is a need to accommodate decision making based on multiple comparisons, especially with the increasing use of systematic reviews and network meta-analyses in guideline development. Furthermore, since the original EtD framework was developed, further relevant GRADE guidance has been developed. The aim of this work was to develop a new EtD framework to accommodate multiple comparisons and reflect current GRADE guidance. The new EtD framework was revised and developed through iterative discussion, feedback, and refinement by the GRADE EtD Project Group and the GRADE Working Group. Experiences and examples from guideline developers, methodological experts, and other stakeholders informed improvements in its structure and usability for multiple comparisons and were subsequently approved by the GRADE Working Group. This article describes the new EtD framework, which now includes 2 corresponding parts for reviews of pairwise and multiple comparisons. The authors describe application to a review with multiple comparisons for the different parts of the EtD framework: the question definition, which now includes the presentation of values of health outcomes and decision thresholds; the assessment section, where the new "net effect" criterion has been included; and the conclusion section, which includes an adaptation for multiple comparisons. The article provides examples and suggestions for presentation of findings. The framework does have limitations, in that its usability has not been tested across a broad spectrum of guideline development contexts.

Systematic reviews can inform research, funding, and guideline decisions. However, it can be challenging to know whether a systematic review has answered a research question conclusively, and it is unclear which methods exist for such assessments.

In the United States, people with disabilities experience disparities in health and health care. Disparities stem from inadequate insurance coverage, physically and culturally inaccessible health care facilities, pervasive harmful misconceptions about disability, and incomprehensive epidemiologic data regarding disability. In this position paper, the American College of Physicians offers recommendations to alleviate health disparities among people with disabilities through policy changes in areas such as health insurance coverage, accessibility of health care facilities, health professional education, research participation, and data collection.

Atopic dermatitis affects approximately 10% of the U.S. population and is more common in children than adults. Up to 99% of physician visits for atopic dermatitis are in primary care. Most cases can be managed successfully with topical treatments, including moisturizers and prescription anti-inflammatory treatments, such as corticosteroids, calcineurin inhibitors, phosphodiesterase-4 inhibitors, Janus kinase (JAK) inhibitors, and aryl hydrocarbon receptor agonists. For more refractory or severe atopic dermatitis, ultraviolet phototherapy and systemic treatments, usually prescribed by specialists, can be used. Systemic treatments include older off-label immunomodulators, such as methotrexate. Since 2017, multiple on-label injectable biologics and oral JAK inhibitors have been approved.